Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients
Background: The nonrandom recurrence of chromosomal abnormalities in multiple myeloma (MM) raises the possibility that they play a role in the pathophysiology and development of the disease. Fluorescence in situ hybridization (FISH) can identify a high frequency of certain abnormalities without the...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-01-01
|
| Series: | Leukemia Research Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048923000328 |
| _version_ | 1797405420140101632 |
|---|---|
| author | Hasna Hamdaoui Badreddine Nouadi Oumaima Benlarroubia Faiza Chbel Chaimaa Saadoune Faïza Bennis Afaf Lamzouri Fatima Chegdani |
| author_facet | Hasna Hamdaoui Badreddine Nouadi Oumaima Benlarroubia Faiza Chbel Chaimaa Saadoune Faïza Bennis Afaf Lamzouri Fatima Chegdani |
| author_sort | Hasna Hamdaoui |
| collection | DOAJ |
| description | Background: The nonrandom recurrence of chromosomal abnormalities in multiple myeloma (MM) raises the possibility that they play a role in the pathophysiology and development of the disease. Fluorescence in situ hybridization (FISH) can identify a high frequency of certain abnormalities without the need for the proliferative and infiltrative index of malignant plasma cells required for conventional cytogenetic analysis. In this study, we describe the association between clinico-biological characteristics and chromosomal abnormalities in 30 Moroccan patients. Methods: The analysis of cytogenetic data, conventional and molecular, of 30 cases of MM, obtained from our previously cytogenetic study, and correlation of the results with the clinico-biological data of these patients. Results: The bone marrow of 5 of 21 patients (23 %) contained a chromosomally abnormal clone, and all karyotypes were complicated (>3 abnormalities). Interphase FISH (iFISH) has detected aberrations in 14 out of 30 (46 %) of the total cases. The proportion of plasma cells in the bone marrow was higher in patients with chromosomal abnormalities (median 29 %) (p = 0.01917) than in patients without abnormalities (median 11 %). Although there was a difference in the median ß-2 microglobulin percentage (13.8 % versus 6.8 %), it was not statistically significant (p = 0.6818). We also, categorized patients into those with a complex clone and those with a sole abnormality. Patients with high bone marrow plasma cell rate (median 45 %) and high rate of ß-2 microglobulin (median 24 %) showed a complex karyotype and a higher iFISH detection rate than those with plasma cells count for (median 20 %) and ß-2 microglobulin count for (median 11 %) but without statistical significance (p = 0.4338 et p = 0.45 respectively). Furthermore, patients with aberrations had significantly shorter overall survival (100 % for 800 days versus 150 days only). Conclusion: Our research has shown that different subgroups of patients with MM can be classified based on the underlying genetic abnormalities. Chromosomal abnormalities (CA) may give the plasma cell a proliferative advantage, increasing the virulence of the disease and affecting overall survival. |
| first_indexed | 2024-03-09T03:10:41Z |
| format | Article |
| id | doaj.art-20d0807d94b841d7a5e76227cac6c4b7 |
| institution | Directory Open Access Journal |
| issn | 2213-0489 |
| language | English |
| last_indexed | 2024-03-09T03:10:41Z |
| publishDate | 2023-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Leukemia Research Reports |
| spelling | doaj.art-20d0807d94b841d7a5e76227cac6c4b72023-12-04T05:21:45ZengElsevierLeukemia Research Reports2213-04892023-01-0120100392Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patientsHasna Hamdaoui0Badreddine Nouadi1Oumaima Benlarroubia2Faiza Chbel3Chaimaa Saadoune4Faïza Bennis5Afaf Lamzouri6Fatima Chegdani7Medical Genetics and Oncogenetics Laboratory, Mohammed VI University Hospital Center, Tangier, Morocco; Immunology and Biodiversity Laboratory, Faculty of Sciences Aïn Chock, Hassan II University of Casablanca, Morocco; National Reference Laboratory, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco; Corresponding author at: Medical Genetics and Oncogenetics Laboratory, Mohammed VI University Hospital Center, Tangier, MoroccoImmunology and Biodiversity Laboratory, Faculty of Sciences Aïn Chock, Hassan II University of Casablanca, MoroccoNational Reference Laboratory, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MoroccoLaboratory of Geosciences and Materials Engineering, École Normale Supérieure, Hassan II University of Casablanca, MoroccoImmunology and Biodiversity Laboratory, Faculty of Sciences Aïn Chock, Hassan II University of Casablanca, MoroccoImmunology and Biodiversity Laboratory, Faculty of Sciences Aïn Chock, Hassan II University of Casablanca, MoroccoMedical Genetics and Oncogenetics Laboratory, Mohammed VI University Hospital Center, Tangier, Morocco; Life and health sciences Laboratory, Faculty of Medicine and Pharmacy of Tangier, Abdelmalek Assaadi University, MoroccoImmunology and Biodiversity Laboratory, Faculty of Sciences Aïn Chock, Hassan II University of Casablanca, MoroccoBackground: The nonrandom recurrence of chromosomal abnormalities in multiple myeloma (MM) raises the possibility that they play a role in the pathophysiology and development of the disease. Fluorescence in situ hybridization (FISH) can identify a high frequency of certain abnormalities without the need for the proliferative and infiltrative index of malignant plasma cells required for conventional cytogenetic analysis. In this study, we describe the association between clinico-biological characteristics and chromosomal abnormalities in 30 Moroccan patients. Methods: The analysis of cytogenetic data, conventional and molecular, of 30 cases of MM, obtained from our previously cytogenetic study, and correlation of the results with the clinico-biological data of these patients. Results: The bone marrow of 5 of 21 patients (23 %) contained a chromosomally abnormal clone, and all karyotypes were complicated (>3 abnormalities). Interphase FISH (iFISH) has detected aberrations in 14 out of 30 (46 %) of the total cases. The proportion of plasma cells in the bone marrow was higher in patients with chromosomal abnormalities (median 29 %) (p = 0.01917) than in patients without abnormalities (median 11 %). Although there was a difference in the median ß-2 microglobulin percentage (13.8 % versus 6.8 %), it was not statistically significant (p = 0.6818). We also, categorized patients into those with a complex clone and those with a sole abnormality. Patients with high bone marrow plasma cell rate (median 45 %) and high rate of ß-2 microglobulin (median 24 %) showed a complex karyotype and a higher iFISH detection rate than those with plasma cells count for (median 20 %) and ß-2 microglobulin count for (median 11 %) but without statistical significance (p = 0.4338 et p = 0.45 respectively). Furthermore, patients with aberrations had significantly shorter overall survival (100 % for 800 days versus 150 days only). Conclusion: Our research has shown that different subgroups of patients with MM can be classified based on the underlying genetic abnormalities. Chromosomal abnormalities (CA) may give the plasma cell a proliferative advantage, increasing the virulence of the disease and affecting overall survival.http://www.sciencedirect.com/science/article/pii/S2213048923000328Multiple myelomaChromosomal abnormalitiesClinic-biological characteristicsFluorescence in situ hybridization (FISH) |
| spellingShingle | Hasna Hamdaoui Badreddine Nouadi Oumaima Benlarroubia Faiza Chbel Chaimaa Saadoune Faïza Bennis Afaf Lamzouri Fatima Chegdani Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients Leukemia Research Reports Multiple myeloma Chromosomal abnormalities Clinic-biological characteristics Fluorescence in situ hybridization (FISH) |
| title | Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients |
| title_full | Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients |
| title_fullStr | Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients |
| title_full_unstemmed | Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients |
| title_short | Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients |
| title_sort | cytogenetic abnormalities correlate with clinico biological characteristics in 30 moroccan multiple myeloma patients |
| topic | Multiple myeloma Chromosomal abnormalities Clinic-biological characteristics Fluorescence in situ hybridization (FISH) |
| url | http://www.sciencedirect.com/science/article/pii/S2213048923000328 |
| work_keys_str_mv | AT hasnahamdaoui cytogeneticabnormalitiescorrelatewithclinicobiologicalcharacteristicsin30moroccanmultiplemyelomapatients AT badreddinenouadi cytogeneticabnormalitiescorrelatewithclinicobiologicalcharacteristicsin30moroccanmultiplemyelomapatients AT oumaimabenlarroubia cytogeneticabnormalitiescorrelatewithclinicobiologicalcharacteristicsin30moroccanmultiplemyelomapatients AT faizachbel cytogeneticabnormalitiescorrelatewithclinicobiologicalcharacteristicsin30moroccanmultiplemyelomapatients AT chaimaasaadoune cytogeneticabnormalitiescorrelatewithclinicobiologicalcharacteristicsin30moroccanmultiplemyelomapatients AT faizabennis cytogeneticabnormalitiescorrelatewithclinicobiologicalcharacteristicsin30moroccanmultiplemyelomapatients AT afaflamzouri cytogeneticabnormalitiescorrelatewithclinicobiologicalcharacteristicsin30moroccanmultiplemyelomapatients AT fatimachegdani cytogeneticabnormalitiescorrelatewithclinicobiologicalcharacteristicsin30moroccanmultiplemyelomapatients |